Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vor Biopharma Inc
(NQ:
VOR
)
0.9539
+0.0339 (+3.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vor Biopharma Inc
< Previous
1
2
3
Next >
VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024
August 09, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024
May 09, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
March 28, 2024
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements.
Via
InvestorPlace
VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023
March 20, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Vor Biopharma: Q4 Earnings Insights
March 20, 2024
Via
Benzinga
The Latest Analyst Ratings for Vor Biopharma
August 14, 2023
Via
Benzinga
What 11 Analyst Ratings Have To Say About Vor Biopharma
June 12, 2023
Via
Benzinga
8 Analysts Have This to Say About Vor Biopharma
May 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 03, 2023
On Tuesday, 647 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 10, 2023
On Thursday, 128 companies set new 52-week lows.
Via
Benzinga
Vor Biopharma: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Where Vor Biopharma Stands With Analysts
March 24, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Truist Securities Maintains Buy Rating for Vor Biopharma: Here's What You Need To Know
March 24, 2023
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
July 05, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
June 09, 2023
Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
Dow Rises 50 Points; Oxford Industries Shares Plunge
March 24, 2023
U.S. stocks pared some losses toward the end of trading, with the Dow Jones and S&P 500 turning higher on Friday. The Dow traded up 0.16% to 32,156.53 while the NASDAQ fell 0.16% to 11,768.17. The S&P...
Via
Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 24, 2023
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Via
Benzinga
Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant
February 16, 2023
Via
Benzinga
Analyzing Vor Biopharma's Short Interest
January 10, 2023
Vor Biopharma's (NASDAQ:VOR) short percent of float has fallen 58.58% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 5.31% of all regular...
Via
Benzinga
Dow Edges Higher; Prometheus Biosciences Shares Jump
December 07, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday.
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
Via
Benzinga
Nasdaq Drops 75 Points; Crude Oil Down 2%
December 07, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 07, 2022
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.